| Mariza A Lirio, MD | |
|
Rt 16 Robert C Byrd Drive, Crab Orchard, WV 25827 | |
| (304) 253-8336 | |
| (304) 253-8337 |
| Full Name | Mariza A Lirio |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | Rt 16 Robert C Byrd Drive, Crab Orchard, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053414268 | NPI | - | NPPES |
| 0130871000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 12066 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mariza A Lirio, MD Po Box 1602, Rt 16, Crab Orchard, WV 25827 Ph: (304) 253-8336 | Mariza A Lirio, MD Rt 16 Robert C Byrd Drive, Crab Orchard, WV 25827 Ph: (304) 253-8336 |
News Archive
Palatin Technologies, Inc., a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced results for its fourth quarter and fiscal year ended June 30, 2012.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced that it has entered into a multi-year agreement with Health Net, Inc. to provide performance management solutions for Health Net's health plan operations and Medicare products. The solutions will enhance Health Net's current data analytics capabilities and include Medical Management Analytics, Provider Network Management Analytics and Operations Performance Management.
A 40 minute test for angina could help patients avoid an overnight stay in hospital, according to research funded by the NIHR Guy's and St Thomas' Biomedical Research Centre.
The Association for Molecular Pathology, the premier global, professional society serving molecular diagnostics professionals, is very concerned and disappointed to see the FDA taking enforcement action against the physicians at Texas Children's Hospital and Houston Methodist Hospital for their laboratory developed procedure (LDP) for Zika virus, which was designed to identify virus-specific RNA sequences in a large metropolitan area.
Pfizer Inc. announced that Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) was introduced into the first childhood immunization program for pneumococcal disease (PD) in the developing world under the auspices of the Advance Market Commitment (AMC) when Nicaragua launched its program today. The AMC is an innovative program which involves private-public partnerships to help make newer vaccines available on a sustainable, affordable and accelerated basis to the least developed countries.
› Verified 6 days ago